Author

Hideto Amano

Observed names: H Amano, H. Amano

Institution: Japan Pharmaceutical Manufacturers Association

Observed institution: Japan Pharmaceutical Manufacturers Association

OpenAlex ID: A5111945690

QT PRODACT: A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles

2005 · Seiji Hayashi, Yoshihide Kii, et al. · Journal of Pharmacological Sciences · 46

Role of Nitric Oxide in the Control of Blood Pressure in Young and Adult Spontaneously Hypertensive Rats

1995 · Y. Akiba, N. Yamaguchi, et al. · Clinical and Experimental Pharmacology and Physiology · 23

QT PRODACT: Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles

2005 · Yoshihide Kii, Seiji Hayashi, et al. · Journal of Pharmacological Sciences · 20

Effect of Repeated Administration of KT3-671,a Nonpeptide AT1 Receptor Antagonist, on Diurnal Variation in Blood Pressure,Heart Rate,and Locomotor Activity in Stroke-Prone Spontaneously

1996 · Koichiro Kawashima, Hideto Amano, et al. · Journal of Cardiovascular Pharmacology · 11

Antihypertensive Effect of Chronic KT3-671, a Structurally New Nonpeptide Angiotensin AT1-Receptor Antagonist, in Stroke-Prone Spontaneously Hypertensive Rats

1995 · Hideto Amano, Kazuko Fujimoto, et al. · The Japanese Journal of Pharmacology · 11

Antihypertensive Effects, Determined by a Telemetry Method, of Trichloromethiazide and 7–o‐ethylfangchinoline, a Derivative of Tetrandrine, in Spontaneously Hypertensive Rats

1995 · K. Kawashima, T. Negishi, et al. · Clinical and Experimental Pharmacology and Physiology · 1

Electrophysiological studies for assessing druginduced QT interval prolongation.(GENERAL SESSION BY POSTER PRESENTATION)(SAFETY PHARMACOLOGY)

2002 · H Amano, Yoshinori Yamamoto, et al. · The Journal of Toxicological Sciences

Protective effects of KT3-671, an angiotensin II AT1 receptor antagonist, on diabetic nephropathy

2000 · Hideto Amano, Kazuhiro Kosakai, et al. · The Japanese Journal of Pharmacology

Effects of KD3-671, an AT1 receptor antagonist, on renal failure in 5/6-nephrectomized rats

1997 · Kazuya Furuta, Hideto Amano, et al. · The Japanese Journal of Pharmacology

Effects of KD3-671, an AT1 receptor antagonist, on blood pressure and organs damage in malignant stroke-prone spontaneously hypertensive rats

1997 · Hideto Amano, Hidetoshi Miyamoto, et al. · The Japanese Journal of Pharmacology

Cardiovascular effects of chronic KT3-671 administration, an orally active angiotensin II (AT1) receptor antagonist, in conscious, freely moving SHRSP.

1993 · Hideto Amano, Kazuko Fujimoto, et al. · The Japanese Journal of Pharmacology

Works count: 11

Citation count: 112

H-index: 5

I10-index: 5